New hope for Alzheimer's psychosis: drug trial targets hallucinations

NCT ID NCT06887192

Recruiting now Symptom relief Sponsor: MapLight Therapeutics Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 26 times

Summary

This study tests an experimental drug called ML-007C-MA to see if it can reduce hallucinations and delusions in people with Alzheimer's disease. About 300 participants aged 55 to 90 will receive either the drug or a placebo. The goal is to improve symptoms without aiming to cure Alzheimer's itself.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSYCHOSIS ASSOCIATED WITH ALZHEIMER'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Clinical Site
RECRUITING

Phoenix, Arizona, 85004, United States
Clinical Site
RECRUITING

Scottsdale, Arizona, 85253, United States
Clinical Site
RECRUITING

Tucson, Arizona, 85704, United States
Clinical Site
RECRUITING

Anaheim, California, 92805, United States
Clinical Site
RECRUITING

Orange, California, 92866, United States
Clinical Site
RECRUITING

San Diego, California, 92123, United States
Clinical Site
RECRUITING

Boca Raton, Florida, 33428, United States
Clinical Site
RECRUITING

Deerfield Beach, Florida, 33442, United States
Clinical Site
RECRUITING

Doral, Florida, 33122, United States
Clinical Site
RECRUITING

Homestead, Florida, 33033, United States
Clinical Site
RECRUITING

Miami, Florida, 33122, United States
Clinical Site
RECRUITING

Miami, Florida, 33155, United States
Clinical Site
RECRUITING

Miami, Florida, 33173, United States
Clinical Site
RECRUITING

Miami, Florida, 33186, United States
Clinical Site
RECRUITING

Miami Gardens, Florida, 33014, United States
Clinical Site
RECRUITING

Miami Gardens, Florida, 33104, United States
Clinical Site
RECRUITING

Naples, Florida, 34105, United States
Clinical Site
RECRUITING

Orlando, Florida, 32807, United States
Clinical Site
RECRUITING

Tampa, Florida, 33629, United States
Clinical Site
RECRUITING

West Palm Beach, Florida, 33407, United States
Clinical Site
RECRUITING

Augusta, Georgia, 30912, United States
Clinical Site
RECRUITING

Las Vegas, Nevada, 89121, United States
Clinical Site
RECRUITING

West Long Branch, New Jersey, 07764, United States
Clinical Site
RECRUITING

Dayton, Ohio, 45459, United States
Clinical Site
RECRUITING

Independence, Ohio, 44131, United States
Clinical Site
RECRUITING

Sugarland, Texas, 77478, United States
Clinical Site
RECRUITING

Bellevue, Washington, 98007, United States
Clinical Site
RECRUITING

Córdoba, Córdoba Province, X5009BIN, Argentina
Clinical Site
RECRUITING

Córdoba, X5004AOA, Argentina
Clinical Site
RECRUITING

Pernik, Pernik, 2304, Bulgaria
Clinical Site
RECRUITING

Sofia, Sofia, 1408, Bulgaria
Clinical Site
NOT_YET_RECRUITING

Brampton, Ontario, L6W 2Z8, Canada
Clinical Site
RECRUITING

London, Ontario, N6A 5W9, Canada
Clinical Site
RECRUITING

Toronto, Ontario, M4N 3M5, Canada
Clinical Site
RECRUITING

Lévis, Quebec, G6V 0C9, Canada
Clinical Site
RECRUITING

Choceň, 565 01, Czechia
Clinical Site
RECRUITING

Toulouse, 31059, France
Clinical Site
RECRUITING

Bucharest, 041914, Romania
Clinical Site
RECRUITING

Daegu, 41404, South Korea
Clinical Site
RECRUITING

Incheon, 21565, South Korea

Conditions

Explore the condition pages connected to this study.

PSYCHOSIS ASSOCIATED WITH ALZHEIMER'S DISEASE